PDE5A and familial dilated cardiomyopathy: In preclinical models of DCM, cardiac dysfunction has been linked to decreased expression of endothelial nitric oxide synthase 3 (NOS3) and increased levels of phosphodiesterase 5A (PDE5A) within myocardial tissues.